Literature DB >> 12230880

The A640G and C242T p22(phox) polymorphisms in patients with coronary artery disease.

A Maziar Zafari1, Madalyn N Davidoff, Harland Austin, Liisa Valppu, George Cotsonis, Bernard Lassègue, Kathy K Griendling.   

Abstract

Oxidative stress plays a significant role in the pathogenesis of coronary artery disease (CAD). A p22(phox)-based NAD(P)H oxidase acts as a potent superoxide-generating system in the vasculature. We studied the association of the A640G and the C242T polymorphisms with clinical risk factors, endothelial function, and severity of CAD in a cohort of 216 patients referred for coronary angiography. The frequency of p22(phox) genotypes for AA, AG, and GG was 22.5, 52.3, and 25.2%, and for CC, CT, and TT 35.5, 51.3, and 13.2%, respectively. The A640G and the C242T polymorphisms were not associated with severity of CAD and endothelial function. The frequency distribution of the genotypes among patients with or without angiographically significant CAD did not reach statistical significance. Our study does not support a functional role for the A640G or C242T polymorphisms either in the severity of CAD or in determining endothelial function in older men.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12230880     DOI: 10.1089/15230860260220184

Source DB:  PubMed          Journal:  Antioxid Redox Signal        ISSN: 1523-0864            Impact factor:   8.401


  12 in total

1.  Myosin regulation in the migration of tumor cells and leukocytes within a three-dimensional collagen matrix.

Authors:  P Bastian; K Lang; B Niggemann; K S Zaenker; F Entschladen
Journal:  Cell Mol Life Sci       Date:  2005-01       Impact factor: 9.261

2.  Haplotype analysis of NAD(P)H oxidase p22 phox polymorphisms in end-stage renal disease.

Authors:  Kent Doi; Eisei Noiri; Akihide Nakao; Toshiro Fujita; Shuzo Kobayashi; Katsushi Tokunaga
Journal:  J Hum Genet       Date:  2005-10-08       Impact factor: 3.172

3.  A copy number variation in human NCF1 and its pseudogenes.

Authors:  Tiffany Brunson; Qingwei Wang; Isfahan Chambers; Qing Song
Journal:  BMC Genet       Date:  2010-02-23       Impact factor: 2.797

4.  Association between NAD(P)H oxidase p22phox gene variants and acute myocardial infarction in a Han Chinese population.

Authors:  H Xu; S Ma; F-Y Tang; Y Chen; H Zhou; M Chen; B Wang; X Liu; X Xie
Journal:  Herz       Date:  2015-12-11       Impact factor: 1.443

Review 5.  Future perspectives for the treatment of pulmonary arterial hypertension.

Authors:  Hossein A Ghofrani; Robyn J Barst; Raymond L Benza; Hunter C Champion; Karen A Fagan; Friedrich Grimminger; Marc Humbert; Gérald Simonneau; Duncan J Stewart; Carlo Ventura; Lewis J Rubin
Journal:  J Am Coll Cardiol       Date:  2009-06-30       Impact factor: 24.094

6.  p22phox C242T Single-Nucleotide Polymorphism Inhibits Inflammatory Oxidative Damage to Endothelial Cells and Vessels.

Authors:  Daniel N Meijles; Lampson M Fan; Maziah M Ghazaly; Brendan Howlin; Martin Krönke; Gavin Brooks; Jian-Mei Li
Journal:  Circulation       Date:  2016-05-09       Impact factor: 29.690

7.  Smoking dose modifies the association between C242T polymorphism and prevalence of metabolic syndrome in a Chinese population.

Authors:  Jiyong Ge; Zhijian Ding; Yu Song; Fangfang Wang
Journal:  PLoS One       Date:  2012-03-01       Impact factor: 3.240

8.  Polymorphisms of C242T and A640G in CYBA gene and the risk of coronary artery disease: a meta-analysis.

Authors:  Qiumei Xu; Fangfen Yuan; Xuemei Shen; Hui Wen; Wei Li; Bei Cheng; Jing Wu
Journal:  PLoS One       Date:  2014-01-02       Impact factor: 3.240

9.  Association between NADPH oxidase p22(phox) C242T polymorphism and ischemic cerebrovascular disease: a meta-analysis.

Authors:  Bing-Hu Li; Li-Li Zhang; Bei-Bei Zhang; Yan-Wei Yin; Li-Meng Dai; Yan Pi; Lu Guo; Chang-Yue Gao; Chuan-Qin Fang; Jing-Zhou Wang; Jing-Cheng Li
Journal:  PLoS One       Date:  2013-02-11       Impact factor: 3.240

10.  Relationship of the p22phox (CYBA) gene polymorphism C242T with risk of coronary artery disease: a meta-analysis.

Authors:  Zhijun Wu; Yuqing Lou; Wei Jin; Yan Liu; Lin Lu; Qiujing Chen; Yucai Xie; Guoping Lu
Journal:  PLoS One       Date:  2013-09-05       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.